The global Insulin Sensitizers market is estimated to be valued at US$ 15.09 billion in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period. This growth can be attributed to two major drivers - the increasing prevalence of diabetes and the rising research and development activities in the healthcare sector.Market Overview:Insulin sensitizers are drugs that help improve the...